Compound 18a5
Compound 18a5 is a lead small molecule for triple-negative breast cancer (TNBC) research, functioning through targeted degradation of Annexin A3 (ANXA3) . It has demonstrated promising activity in both in vitro cellular assays and in vivo xenograft models, supporting its investigation as a potential therapeutic agent.
Product Specifications
Field of Research
Pharmacology & Drug Discovery
Smiles
O=C (CSC (NC1C (N (C (C) C) C (C=CC=C2) =C2C (C3=CC=CC=C3) =N1) =O) =S) N (CC4) CCN4C5=NC=CC=C5
Molecular Formula
C30H32N6O2S2
Molecular Weight
572.74
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS8802847-01 48 Well
Human PAH (Phenylalanine Hydroxylase) ELISA Kit
Sign In for Pricing
View Details MBS8802847-02 96 Well
Human PAH (Phenylalanine Hydroxylase) ELISA Kit
Sign In for Pricing
View Details MBS8802847-03 5x 96 Well
Human PAH (Phenylalanine Hydroxylase) ELISA Kit
Sign In for Pricing
View Details MBS8802847-04 10x 96 Well
Human PAH (Phenylalanine Hydroxylase) ELISA Kit
Sign In for Pricing
View Details 
LS100131980-20ug 20 µg
ZNF705G (NM_001164457) Human Over-expression Lysate
Sign In for Pricing
View Details